AC Immune Ltd (ACIU) — Long-term Investment Intensity
AC Immune Ltd (ACIU) has a Long-term Investment Intensity of 0.4% as of March 2026. Long-term investments of $585.00K represent 0.4% of total assets of $137.42 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ACIU book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AC Immune Ltd Long-term Investment Intensity (2016–2025)
This chart shows how AC Immune Ltd's Long-term Investment Intensity has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the intensity stands at 0.4%, reflecting long-term investments of $585.00K against total assets of $137.42 Million USD. Also explore ACIU total asset value for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for AC Immune Ltd (2016–2025)
The table below presents the year-by-year Long-term Investment Intensity for AC Immune Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see AC Immune Ltd (ACIU) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.4% | $584.00K | $154.43 Million | ▲ +0.2 pp |
| 2024 | 0.2% | $415.00K | $230.91 Million | ▼ 0.0 pp |
| 2023 | 0.2% | $361.00K | $182.81 Million | ▲ +0.0 pp |
| 2022 | 0.2% | $361.00K | $185.94 Million | ▲ +0.1 pp |
| 2021 | 0.1% | $363.00K | $261.44 Million | ▼ 0.0 pp |
| 2020 | 0.1% | $334.00K | $238.74 Million | ▲ +0.0 pp |
| 2019 | 0.1% | $304.00K | $299.25 Million | ▼ -0.1 pp |
| 2018 | 0.2% | $304.00K | $196.56 Million | ▲ +0.1 pp |
| 2017 | 0.1% | $126.00K | $132.01 Million | ▲ +0.0 pp |
| 2016 | 0.1% | $86.00K | $156.10 Million | — |